The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(3R)-3-methyl-4-(1-methyl-7-(1-methyl-1H-pyrazol-5-yl)-3-(1H-pyrazol-5-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl)morpholine ID: ALA5173530
Chembl Id: CHEMBL5173530
PubChem CID: 156404392
Max Phase: Preclinical
Molecular Formula: C18H21N9O
Molecular Weight: 379.43
Associated Items:
Names and Identifiers Canonical SMILES: C[C@@H]1COCCN1c1nc(-c2ccnn2C)c2c(n1)c(-c1ccn[nH]1)nn2C
Standard InChI: InChI=1S/C18H21N9O/c1-11-10-28-9-8-27(11)18-21-15(13-5-7-20-25(13)2)17-16(22-18)14(24-26(17)3)12-4-6-19-23-12/h4-7,11H,8-10H2,1-3H3,(H,19,23)/t11-/m1/s1
Standard InChI Key: AIRFZNQGDRBDOC-LLVKDONJSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 379.43Molecular Weight (Monoisotopic): 379.1869AlogP: 1.38#Rotatable Bonds: 3Polar Surface Area: 102.57Molecular Species: NEUTRALHBA: 9HBD: 1#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.98CX Basic pKa: 2.02CX LogP: 1.51CX LogD: 1.50Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.57Np Likeness Score: -1.57
References 1. Cheng B, Pan W, Xing Y, Xiao Y, Chen J, Xu Z.. (2022) Recent advances in DDR (DNA damage response) inhibitors for cancer therapy., 230 [PMID:35051747 ] [10.1016/j.ejmech.2022.114109 ]